Patients are embracing and exploring alternatives to the traditional office practice, and the expansion of retail health clinics is a big part of that. However, the American College of Physicians said these clinics are best used as a backup alternative to a primary care physician.
Patients are embracing and exploring alternatives to the traditional office practice, and the expansion of retail health clinics is a big part of that. However, the American College of Physicians (ACP) said these clinics are best used as a backup alternative to a primary care physician.
A new position paper from ACP offers recommendations and provides guidance to physicians and their patients in understanding the role retail health clinics should have in providing quick, convenient care.
“A balance must be struck between the convenience and easy access retail clinics provide with the importance of establishing relationships between patients and physicians, particularly for patients who have complex medical histories and/or multiple medical problems,” Wayne J. Riley, MD, MPH, MBA, MACP, president of ACP, said in a statement.
ACP offers 6 recommendations and positions:
“The positions put forward by ACP highlight a meaningful approach that will have positive effects for both patients and physicians,” Dr Riley said. “The health care system will, then, realize the full potential of primary care physicians working collaboratively with retail health clinics.”
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More